Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.8 - $1.22 $67,761 - $103,336
-84,702 Reduced 89.35%
10,092 $9,000
Q4 2022

Feb 13, 2023

SELL
$0.69 - $2.21 $101,705 - $325,754
-147,400 Reduced 60.86%
94,794 $94,000
Q3 2022

Nov 14, 2022

BUY
$0.89 - $1.71 $23,140 - $44,460
26,000 Added 12.03%
242,194 $414,000
Q2 2022

Aug 12, 2022

BUY
$0.88 - $1.91 $37,928 - $82,321
43,100 Added 24.9%
216,194 $209,000
Q1 2022

May 13, 2022

BUY
$1.48 - $2.58 $52,984 - $92,364
35,800 Added 26.08%
173,094 $303,000
Q4 2021

Feb 11, 2022

BUY
$1.9 - $5.6 $32,110 - $94,640
16,900 Added 14.04%
137,294 $314,000
Q3 2021

Nov 12, 2021

SELL
$4.53 - $6.45 $46,659 - $66,435
-10,300 Reduced 7.88%
120,394 $637,000
Q2 2021

Aug 13, 2021

SELL
$6.49 - $9.56 $164,521 - $242,346
-25,350 Reduced 16.25%
130,694 $850,000
Q1 2021

May 13, 2021

SELL
$6.63 - $10.28 $42,299 - $65,586
-6,380 Reduced 3.93%
156,044 $1.34 Million
Q4 2020

Feb 10, 2021

BUY
$5.41 - $7.4 $34,515 - $47,212
6,380 Added 4.09%
162,424 $1.04 Million
Q3 2020

Nov 13, 2020

BUY
$6.09 - $9.15 $323,988 - $486,780
53,200 Added 51.73%
156,044 $1.06 Million
Q2 2020

Aug 13, 2020

BUY
$7.98 - $10.44 $391,020 - $511,560
49,000 Added 91.0%
102,844 $959,000
Q1 2020

May 14, 2020

SELL
$6.03 - $11.01 $57,285 - $104,595
-9,500 Reduced 15.0%
53,844 $538,000
Q4 2019

Feb 13, 2020

BUY
$9.93 - $14.33 $629,005 - $907,719
63,344 New
63,344 $678,000

Others Institutions Holding XFOR

About X4 Pharmaceuticals, Inc


  • Ticker XFOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,646,096
  • Market Cap $23.3M
  • Description
  • X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...
More about XFOR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.